Covering IPOs, Healthcare and Technology Stocks

Andrei Zakharov

Algosun Global

Equity Capital Markets

<p><a href="https://www.smartkarma.com/entities/candela-medical" target="_blank" data-smartkarma-citation="entities:34483:1" rel="noopener">Candela Medical (CDLA US)</a> , pioneer and leader in medical aesthetics market, announced terms of upcoming IPO. A non-surgical aesthetic device company to offer ~14.7 million shares at expected price range of $16-$18 per share, what implies a market cap of ~$1.7 billion at midpoint of the price range. This is the second IPO of leading player in global aesthetics market for the last two years after InMode went public in 2019 and the shares rose more than fivefold since IPO. Candela Medical shares are expected to begin trading on Nasdaq Global Market under the trading symbol “CDLA”. Bank of America, Goldman Sachs and Barclays are leading the IPO.</p>

Candela Medical (CDLA US) , pioneer and leader in medical aesthetics market, announced terms of upcoming IPO. A non-surgical aesthetic device company to offer ~14.7 million shares at expected price range of $16-$18 per share, what implies a market cap of ~$1.7 billion at midpoint of the price range. This is the second IPO of leading player in global aesthetics market for the last two years after InMode went public in 2019 and the shares rose more than fivefold since IPO. Candela Medical shares are expected to begin trading on Nasdaq Global Market under the trading symbol “CDLA”. Bank of America, Goldman Sachs and Barclays are leading the IPO.

Candela Medical IPO: InMode’s Competitor Filed To Go Public

United States

Candela Medical, Inc. develops medical device solutions. The Company offers energy-based solutions for a broad range of aesthetic applications including treatment of benign vascular and pigmented lesions, scars, facial resurfacing, wrinkle reduction, acne, leg veins, cellulite, body shaping, women's health, and hair removal. Candela Medical serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Candela Medical IPO: InMode’s Competitor Filed To Go Public

Candela Medical, leading global aesthetic device company and one of the key competitors of InMode, plans to raise ~$250M at midpoint of the price...

Andrei Zakharov